Artificial intelligence is enormously used in genomics for developing and researching new medicines for treating rare diseases. Moreover, it makes use of several DNA sequencing procedures, bioinformatics and recombinant DNAs for analyzing, arranging, sequencing and functioning of genomes. With machine learning having a prominent role in emergence of genomics, the artificial intelligence in genomics industry is anticipated to witness a huge growth over forecasted time span. Supposedly, genomics produces big data sets which are used in discovering new drugs and AI aids genomics study in producing these new drugs in a short period. Immense use of next generation sequencing in genomics has led to increase in the precision and success of the healthcare sector. Since, it has become vital to integrate this whole genome sequencing method with machine learning for enhancing the medical practice as well as improving the knowledge of diseases such as cancer. This will compel the market growth over 2020-2026. Apart from this, blooming precision medicine market and requirement for exact whole genome synthesis has created major growth avenues for artificial intelligence in genomics industry. In addition to this, artificial intelligence is also utilized in genome field which consists of gene editing, direct-to-consumer genomics and CRISPR as well as developing clinical workflow for improving the patient care, thereby propelling market trends. Moreover, the personalized medicines assist medical professionals to recognize the precise patient requirement, based on that they can prescribe treatment and medicines, which is projected to contribute toward the AI in genomics market growth. In addition, the prevalence of diseases and disorders are at an all-time high. The increasing number of various types of diseases and disorders among a massive chunk of the global populace has resulted in several numbers of discoveries and developments in the pharmaceutical industry. Thus, this aspect will accelerate the demand for Artificial Intelligence in genomics market. Apart from this, the factors such as dearth of a skilled artificial intelligence workforce and lack of regulatory guidelines for medical software are likely to impede the AI in genomics market growth over the forecast period.

In addition to this, machine learning is likely to find wide applications in fields in the predictable future such as farming, pharmacogenomics and newborn genetic screening in the near future. This will generate major growth potential for artificial intelligence in genomics market over the projected timeframe. Furthermore, the key aim of developing AI technologies was to create them human-aware or efficient of human thinking patterns. Thus the above factor is also likely to create lucrative opportunities for the market growth.

The global Artificial Intelligence in Genomics Market is segregated on the basis of Offering as Software and Services. Based on Technology the global Artificial Intelligence in Genomics Market is segmented in Machine Learning and Computer Vision. Based on Application the global Artificial Intelligence in Genomics Market is segmented in Genome Sequencing, Gene Editing and Gene Mapping. Based on End User the global Artificial Intelligence in Genomics Market is segmented in Pharmaceutical Companies and Research Bodies.

The global Artificial Intelligence in Genomics Market report provides geographic analysis covering regions, such as Europe, North America, Asia Pacific, and Rest of The World. The Artificial Intelligence in Genomics Market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Analysis

Allianz, AXA, Nippon Life Insurance, American Intl. Group, Aviva and others are among the major players in the global Artificial Intelligence in Genomics Market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

• In February 2020, the IBM Watson Health made a partnership with Broad Institute of MIT and Harvard (US). An expansion partnership will enable the Broad Institute to analyze and explore genomics data to understand inherent susceptibility.
• In October 2020, the NVIDIA declared a partnership with global healthcare company GSK and its AI group. GSK’s new hub in London is projected to assist its UK based team and scientists from NVIDIA to improve drug and vaccine discovery using NVIDIA platforms.

The global Artificial Intelligence in Genomics Market has been segmented as below:

Artificial Intelligence in Genomics Market, By Offering

• Software
• Services

Artificial Intelligence in Genomics Market, By Technology

• Machine Learning
• Computer Vision

Artificial Intelligence in Genomics Market, By Application

• Genome Sequencing
• Gene Editing
• Gene Mapping

Artificial Intelligence in Genomics Market, By End User

• Pharmaceutical Companies
• Research Bodies

Artificial Intelligence in Genomics Market, By Region

• Europe
• North America
• Asia Pacific
• Rest of The World

Artificial Intelligence in Genomics Market, By Company

• Allianz
• AXA
• Nippon Life Insurance
• American Intl. Group
• Aviva
• Assicurazioni Generali
• Cardinal Health
• State Farm Insurance
• Dai-ichi Mutual Life Insurance
• Munich Re Group
• Zurich Financial Services
• Prudential
• Asahi Mutual Life Insurance
• Sumitomo Life Insurance
• MetLife
• Allstate
• Aegon
• Prudential Financial
• New York Life Insurance
• Meiji Life Insurance
• Aetna
• CNP Assurances
• PingAn
• CPIC

The report covers the below scope:

• Global Artificial Intelligence in Genomics Market sizes from 2020 to 2026, along with CAGR for 2020-2026
• Market size comparison for 2019 vs 2026, with actual data for 2019, estimates for 2019 and forecast from 2020 to 2026
• Global Artificial Intelligence in Genomics Market trends, covering comprehensive range of consumer trends & manufacturer trends
• Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Artificial Intelligence in Genomics Market
• Major market opportunities and challenges in forecast timeframe to be focused
• Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
• Comprehensive company profiles of the key industry players

The years considered for the study are as follows:

• Base year - 2019
• Estimated year - 2019
• Projected year - 2020
• Forecast period - 2021 to 2026

Report Scope:

The global Artificial Intelligence in Genomics Market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Artificial Intelligence in Genomics Market share. Major industry players with significant revenue share include Allianz, AXA, Nippon Life Insurance, American Intl. Group, Aviva, Assicurazioni Generaliand others.

Why to Buy this Report:

• Gain detailed insights on the Artificial Intelligence in Genomics industry trends
• Find complete analysis on the market status
• Identify the Artificial Intelligence in Genomics Market opportunities and growth segments
• Analyze competitive dynamics by evaluating business segments & product portfolios
• Facilitate strategy planning and industry dynamics to enhance decision making

Target Audience:

• The report targeted towards the existing players in the industry is as follows:
• Market Manufacturers/Service Providers
• Market Wholesale/Traders
• Investment and Financial Institutions

Free and Paid Customization based on the requirement